NCT00507117View on ClinicalTrials.gov

Ezopiclone Improves the Quality of Overnight Polysomnography

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

October 31, 2007

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Lunesta

Lunesta 3mg prior to PSG

DRUG

Placebo control

matching placebo

Trial Locations (1)

20307

Walter Reed Army Medical Center, Washington D.C.

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

Walter Reed Army Medical Center

FED

NCT00507117 - Ezopiclone Improves the Quality of Overnight Polysomnography | Biotech Hunter | Biotech Hunter